Loading clinical trials...
Loading clinical trials...
The Effect of Entry Site Distance From Limbus on Perceived Pain During Intravitreal Injection of Anti-VEGF (Vascular Endothelial Growth Factor) Agents
Conditions
Interventions
Intravitreal injection site
Locations
1
United States
University of Texas Medical Branch
Galveston, Texas, United States
Start Date
November 14, 2022
Primary Completion Date
December 18, 2023
Completion Date
September 9, 2024
Last Updated
January 31, 2025
NCT06346132
NCT07482709
NCT07351968
NCT06946290
NCT07041736
NCT07473635
Lead Sponsor
The University of Texas Medical Branch, Galveston
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions